Edesa Biotech (EDSA) Competitors $2.75 -0.13 (-4.51%) Closing price 04:00 PM EasternExtended Trading$2.74 0.00 (-0.18%) As of 04:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock EDSA vs. VNRX, NRXP, HYPD, GANX, RLMD, ANL, ELYM, INKT, OSTX, and DTILShould you be buying Edesa Biotech stock or one of its competitors? The main competitors of Edesa Biotech include VolitionRx (VNRX), NRx Pharmaceuticals (NRXP), Hyperion DeFi (HYPD), Gain Therapeutics (GANX), Relmada Therapeutics (RLMD), Adlai Nortye (ANL), Eliem Therapeutics (ELYM), MiNK Therapeutics (INKT), OS Therapies (OSTX), and Precision BioSciences (DTIL). These companies are all part of the "pharmaceutical products" industry. Edesa Biotech vs. Its Competitors VolitionRx NRx Pharmaceuticals Hyperion DeFi Gain Therapeutics Relmada Therapeutics Adlai Nortye Eliem Therapeutics MiNK Therapeutics OS Therapies Precision BioSciences Edesa Biotech (NASDAQ:EDSA) and VolitionRx (NYSE:VNRX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, media sentiment, dividends, earnings, risk, analyst recommendations, valuation and institutional ownership. Do insiders and institutionals have more ownership in EDSA or VNRX? 5.5% of Edesa Biotech shares are held by institutional investors. Comparatively, 8.1% of VolitionRx shares are held by institutional investors. 22.6% of Edesa Biotech shares are held by insiders. Comparatively, 10.4% of VolitionRx shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media favor EDSA or VNRX? In the previous week, VolitionRx had 2 more articles in the media than Edesa Biotech. MarketBeat recorded 2 mentions for VolitionRx and 0 mentions for Edesa Biotech. VolitionRx's average media sentiment score of 0.15 beat Edesa Biotech's score of 0.00 indicating that VolitionRx is being referred to more favorably in the news media. Company Overall Sentiment Edesa Biotech Neutral VolitionRx Neutral Which has better valuation & earnings, EDSA or VNRX? Edesa Biotech has higher earnings, but lower revenue than VolitionRx. VolitionRx is trading at a lower price-to-earnings ratio than Edesa Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEdesa BiotechN/AN/A-$6.17M-$1.32-2.08VolitionRx$1.32M53.01-$35.32M-$0.25-2.60 Do analysts rate EDSA or VNRX? Edesa Biotech currently has a consensus price target of $5.00, suggesting a potential upside of 81.82%. VolitionRx has a consensus price target of $3.50, suggesting a potential upside of 438.46%. Given VolitionRx's stronger consensus rating and higher probable upside, analysts plainly believe VolitionRx is more favorable than Edesa Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Edesa Biotech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 1 Strong Buy rating(s) 2.50VolitionRx 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has more risk and volatility, EDSA or VNRX? Edesa Biotech has a beta of 0.07, suggesting that its stock price is 93% less volatile than the S&P 500. Comparatively, VolitionRx has a beta of 1.27, suggesting that its stock price is 27% more volatile than the S&P 500. Is EDSA or VNRX more profitable? Edesa Biotech has a net margin of 0.00% compared to VolitionRx's net margin of -2,321.14%. VolitionRx's return on equity of 0.00% beat Edesa Biotech's return on equity.Company Net Margins Return on Equity Return on Assets Edesa BiotechN/A -162.95% -60.33% VolitionRx -2,321.14%N/A -163.39% SummaryVolitionRx beats Edesa Biotech on 11 of the 15 factors compared between the two stocks. Get Edesa Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for EDSA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EDSA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EDSA vs. The Competition Export to ExcelMetricEdesa BiotechMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$19.35M$3.32B$6.11B$10.53BDividend YieldN/A2.29%5.51%4.67%P/E Ratio-2.0821.6185.6926.92Price / SalesN/A424.41583.01184.15Price / CashN/A46.3226.3031.10Price / Book4.5110.0613.246.71Net Income-$6.17M-$52.22M$3.30B$276.35M7 Day Performance11.34%5.87%4.64%3.10%1 Month Performance10.26%12.07%8.36%10.19%1 Year Performance-35.14%26.14%87.97%40.37% Edesa Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EDSAEdesa Biotech2.581 of 5 stars$2.75-4.5%$5.00+81.8%-32.4%$19.35MN/A-2.0820VNRXVolitionRx2.293 of 5 stars$0.63+1.4%$3.50+453.8%-27.0%$68M$1.32M-1.7680Gap UpNRXPNRx Pharmaceuticals3.211 of 5 stars$3.42+5.2%$34.50+908.8%+117.5%$67.73MN/A-1.532HYPDHyperion DeFi0.5851 of 5 stars$9.73-5.0%$2.00-79.4%-73.1%$67.72M$60K-0.1740Gap DownGANXGain Therapeutics3.049 of 5 stars$1.88+3.6%$8.00+326.7%+22.0%$67.41M$50K-2.9820News CoverageAnalyst ForecastOptions VolumeRLMDRelmada Therapeutics2.4001 of 5 stars$2.00+6.5%$1.00-50.0%-40.2%$67.38MN/A-0.9110News CoverageANLAdlai Nortye1.9714 of 5 stars$1.79+4.1%$9.00+402.8%-6.4%$66.05M$5M0.00127Positive NewsELYMEliem TherapeuticsN/A$2.13+1.4%N/A-61.6%$63.37MN/A-4.029News CoverageINKTMiNK Therapeutics2.6277 of 5 stars$14.00+2.2%$37.50+168.0%+111.8%$63.30MN/A-4.8630OSTXOS TherapiesN/A$1.96-2.3%$18.00+817.0%N/A$62.37MN/A-2.49N/ADTILPrecision BioSciences4.0407 of 5 stars$5.20+2.1%$47.00+804.7%-39.7%$61.90M$68.70M-0.60200News Coverage Related Companies and Tools Related Companies VNRX Competitors NRXP Competitors HYPD Competitors GANX Competitors RLMD Competitors ANL Competitors ELYM Competitors INKT Competitors OSTX Competitors DTIL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EDSA) was last updated on 10/7/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edesa Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edesa Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
